Celltech Group Plc announces Holding(s) in Company

Slough, Berkshire, UNITED KINGDOM


Slough, U.K., Dec. 10, 2003 (PRIMEZONE) -- Celltech Group Plc:

SCHEDULE 10

NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Name of company

Celltech Group plc

2. Name of shareholder having a major interest

Goldman Sachs Group

3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18

As in 2 above

4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them



 Goldman Sachs Securities (Nominees) Limited                6,923,935

 Goldman Sachs Securities (Nominees) Limited                  171,930

 Depositary Trust Company of New York                          39,740

 Depositary Trust Company of New York                             800

 Crest account Creptemp                                     1,442,217

5. Number of shares / amount of stock acquired

Unknown

6. Percentage of issued class

Unknown

7. Number of shares / amount of stock disposed

Unknown

8. Percentage of issued class

Unknown

9. Class of security

Ordinary 50p shares

10. Date of transaction

Unknown

11. Date company informed

9 December 2003

12. Total holding following this notification

8,578,622

13. Total percentage holding of issued class following this notification

3.08%

14. Any additional information

15. Name of contact and telephone number for queries

Cheryl Cramer Tel. 01753 447933

16. Name and signature of authorised company official responsible for making this notification

J A D Slater

Date of notification

10 December 2003

The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material.


            This information is provided by RNS 
 The company news service from the London Stock Exchange


        

Contact Data